FUnctional Genomics in SEvere infections

FUSE

About this project

Hypothesis

Sepsis manifests as a systemic inflammatory response to severe infection, marked by immune system dysregulation, which can lead to organ dysfunction and, in complicated cases, death. Worldwide, the estimated annual incidence of sepsis is 49 million cases. The mortality rate of sepsis is placed at 20% of all causes, with 11 million deaths reported each year; in areas with limited medical resources mortality could be much higher. 1–3 Similar data could also be extrapolated for Romania, but to our best knowledge, there were no documenting studies or reports on the epidemiology of sepsis in our country, which highlighted the acute need for the implementation of the present application.
FUSE (2016-2020) was the first study aiming to identify and describe the impact of the microbiome on immune system function in sepsis, and to provide an additional association with other functional parameters of the host. In addition, this project was the first to evaluate, in a complex model, the interaction between the bacteriome and host genetics, and the resulting effect on the immune response in the Romanian population. FUSE wished to rise awareness about the healthcare threat that sepsis poses, by bringing together the most active research groups studying sepsis in Romania and abroad.
The project followed the general hypothesis that the host defence against sepsis is determined by the genetic background of the host (genome) and the interaction between the pathogen and the colonising bacteria and fungi (bacteriome, mycobiome). This interaction is altered in patients with sepsis, and the identification of the originating disequilibrium could lead to the discovery of new therapeutic targets.

Objectives

1. Describing the interaction between the host genome and the bacterial and fungal flora (bacteriome and mycobiome), and its effects on immunity in healthy individuals;
2. Identifying the disequilibrium stemming from these interactions in patients with sepsis, and their association with sepsis severity, in order to design new therapeutic strategies.

The techniques employed included immune cell isolation, ex-vivo stimulation experiments, quantitative cytokine assays (ELISA), protein quantification by Western blot, and targeted modulation of gene expression by transfection (siRNA silencing).  Through this processing stream, we wished to correlate genotyping data with the functional impact of the detected genetic variants, with the aim of detailing the consequences of genetic variation at RNA transcript level and protein production, in the context of functional immunology.

The knowledge from this project was also intended to be of potential use in the research on other inflammatory diseases, where similar techniques are applied, and accelerated by the already established network of collaborations of FUSE applicators with researchers from other areas of expertise. This approach targeted research support and quality and expansion of research and diagnostic capacity in sepsis.

The results from the FUSE project so far published included the discovery of two separate inflammatory endotypes described for the severe infection cohort evaluated in Romania. Extensive study data is currently being analysed for publishing.

1.     Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet Lond. Engl. 395, 200–211 (2020).
2.     Evans, L. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit. Care Med. 49, e1063 (2021).
3.     Gotts, J. E. & Matthay, M. A. Sepsis: pathophysiology and clinical management. BMJ 353, i1585 (2016).

Teams

Our research team at the Medical Genetics Department of UMF Cluj-Napoca studies the mechanisms of inflammatory diseases and their interrelationship with individual genetic susceptibility factors. We are curious how the variance in our genome or epigenome can alter the immunological processes and cause inflammatory disease. We assess immunological functions of primary cells in patient cohorts and in controls and we use multi-omics to assess the different molecular layers that can contribute to inflammatory dysregulation. Currently, we are investigating the mechanisms of immune memory associated to long term proinflammatory effects and accelerated immunological aging in gout, hyperuricemia, systemic sclerosis and other autoinflammatory and autoimmune disorders.

Craiova Human genomics

Cluj Functional Genomics

Cluj Medical Genetics

Cluj Rheumatology

Cluj Infectious Diseases

Stay Informed

Follow us on our social media

Get access to groundbreaking research, events, and scientific insights from the HFGP Romania.

Scroll to Top